555 related articles for article (PubMed ID: 34610990)
1. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.
Palaiodimou L; Stefanou MI; Katsanos AH; Aguiar de Sousa D; Coutinho JM; Lagiou P; Michopoulos I; Naska A; Giannopoulos S; Vadikolias K; Voumvourakis KI; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Tsivgoulis G
Neurology; 2021 Nov; 97(21):e2136-e2147. PubMed ID: 34610990
[TBL] [Abstract][Full Text] [Related]
2. Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis.
Palaiodimou L; Stefanou MI; de Sousa DA; Coutinho JM; Papadopoulou M; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Filippou DK; Tsivgoulis G
J Neurol; 2022 Jul; 269(7):3413-3419. PubMed ID: 35394172
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
[TBL] [Abstract][Full Text] [Related]
5. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
[TBL] [Abstract][Full Text] [Related]
6. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review.
Jaiswal V; Nepal G; Dijamco P; Ishak A; Dagar M; Sarfraz Z; Shama N; Sarfraz A; Lnu K; Mitra S; Agarwala P; Naz S; Song D; Jaiswal A
J Prim Care Community Health; 2022; 13():21501319221074450. PubMed ID: 35142234
[TBL] [Abstract][Full Text] [Related]
8. First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
Kerr S; Joy M; Torabi F; Bedston S; Akbari A; Agrawal U; Beggs J; Bradley D; Chuter A; Docherty AB; Ford D; Hobbs R; Katikireddi SV; Lowthian E; de Lusignan S; Lyons R; Marple J; McCowan C; McGagh D; McMenamin J; Moore E; Murray JK; Owen RK; Pan J; Ritchie L; Shah SA; Shi T; Stock S; Tsang RSM; Vasileiou E; Woolhouse M; Simpson CR; Robertson C; Sheikh A
PLoS Med; 2022 Feb; 19(2):e1003927. PubMed ID: 35192598
[TBL] [Abstract][Full Text] [Related]
9. [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination].
Kawano H; Hashimoto Y; Hirano T
Rinsho Shinkeigaku; 2021 Sep; 61(9):594-601. PubMed ID: 34373413
[TBL] [Abstract][Full Text] [Related]
10. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.
Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A
Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205
[TBL] [Abstract][Full Text] [Related]
11. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
[TBL] [Abstract][Full Text] [Related]
12. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries.
van de Munckhof A; Borhani-Haghighi A; Aaron S; Krzywicka K; van Kammen MS; Cordonnier C; Kleinig TJ; Field TS; Poli S; Lemmens R; Scutelnic A; Lindgren E; Duan J; Arslan Y; van Gorp EC; Kremer Hovinga JA; Günther A; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; de Sousa DA; Wasay M; Arauz A; Conforto AB; Ferro JM; Coutinho JM;
Int J Stroke; 2023 Oct; 18(9):1112-1120. PubMed ID: 37277922
[TBL] [Abstract][Full Text] [Related]
13. Incidence of thrombocytopenia-associated cerebral venous sinus thrombosis: a population-based study.
Mahadevan JJ; Psaltis PJ; Thrift AG; Kleinig TJ
BMJ Neurol Open; 2024; 6(1):e000605. PubMed ID: 38757112
[TBL] [Abstract][Full Text] [Related]
14. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
16. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
Krzywicka K; Aguiar de Sousa D; Cordonnier C; Bode FJ; Field TS; Michalski D; Pelz J; Skjelland M; Wiedmann M; Zimmermann J; Wittstock M; Zanotti B; Ciccone A; Bandettini di Poggio M; Borhani-Haghighi A; Chatterton S; Aujayeb A; Devroye A; Dizonno V; Geeraerts T; Giammello F; Günther A; Ichaporia NR; Kleinig T; Kristoffersen ES; Lemmens R; De Maistre E; Mirzaasgari Z; Payen JF; Putaala J; Petruzzellis M; Raposo N; Sadeghi-Hokmabadi E; Schoenenberger S; Umaiorubahan M; Sylaja PN; van de Munckhof A; Sánchez van Kammen M; Lindgren E; Jood K; Scutelnic A; Heldner MR; Poli S; Kruip MJHA; Arauz A; Conforto AB; Aaron S; Middeldorp S; Tatlisumak T; Arnold M; Coutinho JM; Ferro JM;
Eur J Neurol; 2023 May; 30(5):1335-1345. PubMed ID: 36773014
[TBL] [Abstract][Full Text] [Related]
17. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT
MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis and Bleeding in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Systematic Review of Published Cases.
Clerici B; Pontisso E; Aloise C; Peroni B; Perricone R; Pisetta C; Scavone M; Birocchi S; Podda GM
Thromb Haemost; 2024 May; 124(5):423-431. PubMed ID: 38109906
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.
Lai CC; Ko WC; Chen CJ; Chen PY; Huang YC; Lee PI; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1027-1035. PubMed ID: 34176415
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.
Waqar U; Ahmed S; Gardezi SMHA; Tahir MS; Abidin ZU; Hussain A; Ali N; Mahmood SF
Clin Appl Thromb Hemost; 2021; 27():10760296211068487. PubMed ID: 34907794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
